She received her M.Eng in Electrical Engineering at the University of Louisville and her PhD in Biomedical Engineering from Johns Hopkins University. The Carter Lab uses bioinformatics and computational biology to study the role of inherited and acquired genetic variation in cancer. The goals of her research are to advance precision cancer medicine by developing approaches to discriminate drivers from passengers, predict cancer cell-specific therapeutic vulnerabilities and identify germline variation that contributes to the emergence or progression of tumors. Dr. Carter is a Siebel Scholar and a recipient of a 2013 NIH Director’s Early Independence Award.